首页> 美国卫生研究院文献>Gene Regulation and Systems Biology >Pathway-Based Analysis of the Liver Response to IntravenousMethylprednisolone Administration in Rats: Acute Versus ChronicDosing
【2h】

Pathway-Based Analysis of the Liver Response to IntravenousMethylprednisolone Administration in Rats: Acute Versus ChronicDosing

机译:基于途径的肝对静脉反应的分析大鼠甲基强的松龙给药:急性与慢性加药

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pharmacological time-series data, from comparative dosing studies, are critical to characterizing drug effects. Reconciling the data from multiple studies is inevitably difficu multiple in vivo high-throughput -omics studies are necessary to capture the global and temporal effects of the drug, but these experiments, though analogous, differ in (microarray or other) platforms, time-scales, and dosing regimens and thus cannot be directly combined or compared. This investigation addresses this reconciliation issue with a meta-analysis technique aimed at assessing the intrinsic activity at the pathway level. The purpose of this is to characterize the dosing effects of methylprednisolone (MPL), a widely used anti-inflammatory and immunosuppressive corticosteroid (CS), within the liver. A multivariate decomposition approach is applied to analyze acute and chronic MPL dosing in male adrenalectomized rats and characterize the dosing-dependent differences in the dynamic response of MPL-responsive signaling and metabolic pathways. We demonstrate how to deconstruct signaling and metabolic pathways into their constituent pathway activities, activities which are scored for intrinsic pathway activity. Dosing-induced changes in the dynamics of pathway activities are compared usinga model-based assessment of pathway dynamics, extending the principles ofpharmacokinetics/pharmacodynamics (PKPD) to describe pathway activities. Themodel-based approach enabled us to hypothesize on the likely emergence (ordisappearance) of indirect dosing-dependent regulatory interactions, pointing tolikely mechanistic implications of dosing of MPL transcriptional regulation.Both acute and chronic MPL administration induced a strong core of activitywithin pathway families including the following: lipid metabolism, amino acidmetabolism, carbohydrate metabolism, metabolism of cofactors and vitamins,regulation of essential organelles, and xenobiotic metabolism pathway families.Pathway activities alter between acute and chronic dosing, indicating that MPLresponse is dosing dependent. Furthermore, because multiple pathway activitiesare dominant within a single pathway, we observe that pathways cannot be definedby a single response. Instead, pathways are defined by multiple, complex, andtemporally related activities corresponding to different subgroups of geneswithin each pathway.
机译:来自对比剂量研究的药理学时序数据对于表征药物作用至关重要。整合多个研究的数据不可避免地很困​​难;多个体内高通量组学研究对于捕获药物的总体和时间效应是必要的,但是这些实验尽管类似,但在(微阵列或其他)平台,时间尺度和给药方案方面有所不同,因此不能直接进行合并或比较。这项研究使用旨在评估途径水平内在活性的荟萃分析技术解决了这一对账问题。这样做的目的是表征甲基强的松龙(MPL)在肝脏中的剂量作用,MPL是一种广泛使用的抗炎和免疫抑制性皮质类固醇(CS)。应用多元分解方法分析雄性肾上腺切除大鼠的急性和慢性MPL剂量,并表征MPL反应性信号和代谢途径的动态反应中剂量依赖性差异。我们展示了如何将信号和代谢途径解构为它们的组成途径活动,这些活动对内在途径活动进行了评分。使用以下方法比较剂量诱导的途径活动动力学变化基于模型的路径动力学评估,扩展了原理药代动力学/药效学(PKPD)来描述途径活性。的基于模型的方法使我们能够推测可能出现的情况(或消失)的间接剂量依赖性调节相互作用,指向MPL转录调节的剂量可能具有机械学意义。急性和慢性MPL给药均可诱导强大的活动核心途径家族中包括以下物质:脂质代谢,氨基酸代谢,碳水化合物代谢,辅助因子和维生素的代谢,调节基本细胞器和异种代谢途径家族。急性和慢性给药之间的途径活动发生变化,表明MPL反应取决于剂量。此外,由于多种途径的活动在单一途径中占主导地位,我们观察到无法定义途径一次回应。相反,路径是由多个,复杂的和与基因不同亚组相对应的与时间相关的活动在每个途径中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号